41954:PROSTATE SPECIFIC ANTIGEN (PSA), SCREENING

Print View Attached Docs:Physician Update: PSA Transition Requires Re-establishing Baselines (11/07)
41954:PROSTATE SPECIFIC ANTIGEN (PSA), SCREENING
Alias Names: PSA Ultrasensitive Screen
Methodology: Chemiluminescence Immunoassay (CLIA)
Edit Date: 12/23/2009
Performed: Daily
Released: Same day as tested
CPT Code: 84153
Specimen Collection Details
Collection: One 7.5 mL serum separator tube (SST). Also acceptable: One 5 mL red top tube. NOTE: Specimen should be collected before such prostatic manipulations as DRE, prostatic massage, TRUS, or prostatic biopsy.
Handling: Allow to clot, centrifuge and separate serum from cells within 3 hours. Refrigerate at 2-8° C. Freeze if specimen cannot be assayed within 48 hours. Do not allow more than two freeze/thaw cycles..
To assure accurate matching for historical graph, patient’s Social Security Number is requested in addition to date of birth.
Stability: 48 hours refrigerated or 5 months frozen at -20° C.
Standard Volume: 1 mL serum.
Minimum Volume: 0.5 mL serum.
Transport: Refrigerated, or frozen on dry ice.
Comments: This is a Hybritech 3rd Generation (Ultrasensitive) equimolar Total PSA with a clinical sensitivity of 0.008 ng/mL.
Rejection Criteria: Plasma; specimen frozen and thawed more than twice.
MEDICARE MAY REQUIRE A SIGNED ADVANCE BENEFICIARY NOTICE (ABN) FOR THIS TEST

PeaceHealth Laboratories